ArticleCureus2025
Exploratory Analysis on the Role of Video Tools and Multidisciplinary Healthcare Providers to Aid Counselling for Buprenorphine/Naloxone Induction Within the Evaluating Microdosing in the Emergency Department Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction To address the rising deaths and hospitalizations related to opioid toxicity, buprenorphine/naloxone has been provided as a frontline treatment within the emergency department (ED), allowing increased access to opioid agonist therapies (OAT). However, several barriers exist toward initiating patients on buprenorphine/naloxone within the ED, such as shortages in healthcare staff and time limitations in the urgent ED environment. To overcome these barriers, we utilized counselling tools and engaged multidisciplinary healthcare providers to counsel patients for our study, Evaluating Microdosing in the Emergency Department (EMED). The primary objective of this analysis is to describe the proportion of healthcare providers counselling for buprenorphine/naloxone induction within the EMED study, before and after the implementation of a counselling video, and across different time intervals. Additionally, we aim to compare the completion status of enrollment when patients were counselled by different types of healthcare providers. By analyzing these factors, we aim to explore how collaboration with multidisciplinary healthcare providers and the use of video tools can impact buprenorphine/naloxone induction in the ED, thereby increasing accessibility of take-home OAT. Methods Data regarding the type of healthcare worker providing counselling for the EMED study was collected at Vancouver General Hospital from July 23, 2021, to December 31, 2023. The EMED study is an open-label, randomized controlled trial comparing microdosing and standard dosing take-home regimens. We analyzed 172 providers involved in counselling patients for the study. We stratified the data by month, week, and day of the week to assess trends in counselling frequencies. Results We found a statistically significant increase in the proportion of emergency physicians counselling after the implementation of the counselling video. Specifically, we found there was a statistically significant increase in the evenings. Furthermore, we found that pharmacists completed a greater proportion of counselling for buprenorphine/naloxone induction throughout the study period, and there was no statistically significant difference between the completion status of enrollment when counselled by either provider. Conclusion We can improve patient access to buprenorphine/naloxone induction counselling by utilizing an adjunct video tool and distributing workload between emergency physicians and clinical pharmacists. Future sites interested in providing take-home buprenorphine/naloxone kits may benefit from implementing video tools and involving clinical pharmacists to mitigate workflow burdens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.